Single Cell Genotypic and Phenotypic Analysis of Measurable Residual Disease in Acute Myeloid Leukemia

被引：3
|
作者：
Robinson, Troy [1 ,2 ]
Bowman, Robert L. [2 ,3 ]
Persaud, Sonali [2 ]
Liu, Ying [4 ,5 ]
Gao, Qi [6 ]
Zhang, Jing-Ping [7 ]
Sun, Xiaotian [6 ]
Sciambi, Adam [8 ]
Llanso, Aaron [9 ]
Famulare, Christopher [10 ]
Goldberg, Aaron D. [11 ]
Dogan, Ahmet [6 ]
Roshal, Mikhail [6 ]
Levine, Ross L. [2 ,10 ,11 ,12 ]
Xiao, Wenbin [2 ,6 ,10 ]
机构：
[1] Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Ctr Epigenet Res, New York, NY 10021 USA
[4] Mem Sloan Kettering, Hematopathol Serv, Dept Pathol & Lab Med, New York, NY USA
[5] Mem Sloan Kettering, Mol Diagnost Serv, Dept Pathol & Lab Med, New York, NY USA
[6] Mem Sloan Kettering Canc Ctr, Dept Pathol & Lab Med, Hematopathol Serv, New York, NY USA
[7] Mem Sloan Kettering Canc Ctr, Dept Pathol, Hematopathol Serv, New York, NY 10021 USA
[8] Mission Bio Inc, San Francisco, CA USA
[9] Mission Bio, San Francisco, CA USA
[10] Mem Sloan Kettering Canc Ctr, Ctr Hematol Malignancies, New York, NY 10021 USA
[11] Mem Sloan Kettering Canc Ctr, Dept Med, Leukemia Serv, New York, NY 10021 USA
[12] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-166501
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2275 / 2277
页数：3
相关论文
共 50 条
  • [21] Role of Measurable Residual Disease in Older Adult Acute Myeloid Leukemia
    Li, Xueyao
    Tong, Xiuzhen
    CLINICAL INTERVENTIONS IN AGING, 2023, 18 : 921 - 931
  • [22] Widespread Use of Measurable Residual Disease in Acute Myeloid Leukemia Practice
    Epstein-Peterson, Zachary D.
    Devlin, Sean M.
    Stein, Eytan M.
    Estey, Elihu H.
    Tallman, Martin S.
    BLOOD, 2017, 130
  • [23] Measurable residual disease in chronic myeloid leukemia
    Branford, Susan
    Apperley, Jane F.
    HAEMATOLOGICA, 2022, 107 (12) : 2794 - 2809
  • [24] Reproducibility of measurable residual disease detection by flow cytometry in acute myeloid leukemia
    Roehnert, M. A.
    Kramer, M.
    Schadt, J.
    Ensel, P.
    Thiede, C.
    Krause, S.
    Buecklein, V
    Hoffmann, J.
    Jaramillo, S.
    Schlenk, R.
    Roellig, C.
    Bornhaeuser, M.
    McCarthy, N.
    Freeman, S.
    Oelschlaegel, U.
    von Bonin, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 278 - 278
  • [25] Current treatment strategies for measurable residual disease in patients with acute myeloid leukemia
    Percival, Mary-Elizabeth M.
    Estey, Elihu H.
    CANCER, 2019, 125 (18) : 3121 - 3130
  • [26] Measurable residual disease in multiple myeloma and in acute myeloid leukemia, an evolving topic
    Castelli, Germana
    Pelosi, Elvira
    Testa, Ugo
    ANNALI DELL ISTITUTO SUPERIORE DI SANITA, 2021, 57 (04): : 300 - 313
  • [27] Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia
    Gaut, Daria
    Oliai, Caspian
    Boiarsky, Jonathan
    Zhang, Shiliang
    Salhotra, Amandeep
    Azenkot, Tali
    Kennedy, Vanessa E.
    Khanna, Vishesh
    Olmedo Gutierrez, Karla
    Shukla, Navika
    Moskoff, Benjamin
    Park, Gabriel
    Afkhami, Michelle
    Patel, Anand
    Jeyakumar, Deepa
    Mannis, Gabriel
    Logan, Aaron C.
    Jonas, Brian A.
    Schiller, Gary
    LEUKEMIA & LYMPHOMA, 2024, 65 (01) : 69 - 77
  • [28] Current strategies for detection and approach to measurable residual disease in acute myeloid leukemia
    Palmieri, Raffaele
    Buccisano, Francesco
    Maurillo, Luca
    Del Principe, Maria, I
    Paterno, Giovangiacinto
    Venditti, Adriano
    Martinelli, Giovanni
    Cerchione, Claudio
    MINERVA MEDICA, 2020, 111 (05) : 386 - 394
  • [29] Detection and management of acute myeloid leukemia measurable residual disease: is it standard of care?
    Paterno, Giovangiacinto
    Del Principe, Maria Ilaria
    Venditti, Adriano
    CURRENT OPINION IN HEMATOLOGY, 2020, 27 (02) : 81 - 87
  • [30] Measurable residual disease as a biomarker in acute myeloid leukemia: theoretical and practical considerations
    Walter, Roland B.
    Ofran, Yishai
    Wierzbowska, Agnieszka
    Ravandi, Farhad
    Hourigan, Christopher S.
    Ngai, Lok Lam
    Venditti, Adriano
    Buccisano, Francesco
    Ossenkoppele, Gert J.
    Roboz, Gail J.
    LEUKEMIA, 2021, 35 (06) : 1529 - 1538
12345